ID
ELGX

Integral Derivatives’s Endologix Inc ELGX Stock Holding History

Integral Derivatives’s Portfolio ELGX Stock Details ELGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,484
Closed -$85K – 1467
2016
Q4 		$85K Buy
+1,484
New +$136K ﹤0.01% 1073

Other funds holding ELGX

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Integral Derivatives's ELGX Position: Q1 2017 in Review

Integral Derivatives sold out of Endologix Inc (ELGX) in Q1 2017, closing a stake of 1,484 shares — an estimated $85K sold.

Integral Derivatives first reported a position in ELGX in Q4 2016 and held it in 1 quarter. The position peaked at $85K in Q4 2016. 129 funds tracked by Wall St. Rank hold ELGX as of Q1 2017.

  • Integral Derivatives reported no remaining Endologix Inc position as of Q1 2017 after selling out during the quarter.
  • Integral Derivatives sold 1,484 Endologix Inc shares in Q1 2017, an estimated $85K.
  • Integral Derivatives first reported a position in Endologix Inc in Q4 2016 and held it in 1 quarter.
  • Integral Derivatives's Endologix Inc position peaked at $85K in Q4 2016.
  • 129 funds tracked by Wall St. Rank held Endologix Inc as of Q1 2017.

Based on Integral Derivatives's 13F filing for Q1 2017, filed 15 May 2017.